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Abstract: We investigated the implication of AMP-activated protein kinase (AMPK) in melatonin-induced protection in a renal
ischemia/reperfusion (I/R) model. Animals were divided into four groups: rats of the sham group were not subjected to renal I/R. Rats
in the I/R group received the vehicle 30 min before renal ischemia for 1 h followed by reperfusion for 6 h. Rats in the Mel+I/R group
received melatonin (10 mg/kg) 30 min before the onset of I/R. Rats in the Mel+I/R+araA group received araA (AMPK inhibitor, 100
µg/kg per min for 10 min) just before melatonin administration. The results showed that melatonin treatment induced a significant
improvement in renal function, morphology, and antioxidant status, as well as Akt pathway activation. It also decreased cytolysis and
endoplasmic reticulum stress. Inhibition of AMPK by araA administration completely abolished the effects of melatonin in regard to the
above parameters except for Akt and some of its downstream target molecules. These results demonstrate that the effects of melatonin
on renal I/R are, for the most part, linked to AMPK activation, with the exception of the Akt pathway, which seems to be independent
of AMPK.
Key words: Ischemia/reperfusion, kidney, melatonin, AMP-activated protein kinase, oxidative stress, Akt

1. Introduction
Acute kidney injury remains an important health concern
due to the high morbidity and mortality rates. It is most
frequently caused by ischemia/reperfusion (I/R) syndrome
(Kumagai et al., 2009). Ischemia starves cells of oxygen and
nutrients, resulting in depletion of ATP, accumulation of
waste products, and production of reactive oxygen species
(ROS). Restitution of blood flow with reperfusion sustains
renal injury through further generation of ROS (Bidmon
et al., 2012). ROS are capable of reacting with proteins,
lipids, and nucleic acids leading to protein denaturation,
lipid peroxidation, and DNA damage (Bidmon et al., 2012;
Wang et al., 2012a). Many antioxidants have been the focus
of studies for developing strategies for use in I/R therapy
(Mahfoudh Boussaid et al., 2007; Wang et al., 2012a;
Aydogan et al., 2013). Along with others, we have shown
that the antioxidant molecule, melatonin, has a significant
protective action against renal damage that occurs during I/R
* Correspondence: hbenabdennebi@yahoo.fr

injury (Aktoz et al., 2007; Ersoz et al., 2009; Hadj Ayed Tka
et al., 2015). Effectively, there is a wide range of intracellular
pathways that intervene in melatonin protection, but a
cogent description of how they relate to each other is lacking.
A growing body of evidence has proven that AMPactivated protein kinase (AMPK) is a key modulator of
cell survival under conditions that increase intracellular
AMP, such as hypoxia (Hardie and Carling, 1997). It is a
master metabolic regulator that orchestrates the regulation
of cellular energy homeostasis (Sid al., 2013). Moreover,
AMPK was shown to play a crucial role in defending
various organs including the liver (Peralta et al., 2001), the
kidney (Lempiäinen et al., 2012), and the heart (Morrison
et al., 2011) against I/R injury. On the basis of this, it would
be interesting to investigate its possible involvement in
melatonin-induced protection during I/R. Therefore, the
aim of this study was to explore whether and to what
extent AMPK mediates this protection.
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2. Materials and methods
2.1. Animals and drugs
All animal care and experimental protocols complied with
the European Union Regulations (Directive 86/609 EEC)
for animal experiments. Adult male Wistar rats (200–250
g) were housed under standard conditions (12 h light/
dark cycle) and were permitted ad libitum access to water
and food. Melatonin (Sigma, St Louis, MO, USA) was
dissolved in ethanol and further diluted in saline (0.9%
NaCl) to produce a final alcohol concentration of 1% and
was administered at a dose of 10 mg/kg via intraperitoneal
(i.p.) route (Ersoz et al., 2009; Sehajpal et al., 2014). Adenine
9-β-D-arabinofuranoside (araA; Sigma), an inhibitor
of AMPK, was dissolved in saline (0.9% NaCl) and was
infused at a dose of 100 µg/kg per min intravenously (i.v.)
for 10 min (Zaouali et al., 2013).
2.2. Experimental groups
Rats were randomly assigned to one of the following
experimental groups, each of them consisting of six
animals:
Sham group: animals in this group were sham
operated, and both renal pedicles were exposed but were
not subjected to I/R.
I/R group: animals received the vehicle (ethanol +
NaCl 0.9%, i.p.) 30 min before they were subjected to 60
min of renal ischemia followed by reperfusion for 6 h
(Ersoz et al., 2009).
Mel+I/R group: animals were injected with melatonin
(10 mg/kg) 30 min before the onset of I/R.
Mel+I/R+araA group: same treatment as in the
previous group, but animals were treated with araA (100
µg/kg per min) just before melatonin injection.
2.3. Surgery and experimental design
Anesthesia was achieved with an injection of ketamine
hydrochloride (50 mg/kg, i.p.) and xylazine (10 mg/kg,
i.p.), and the body temperature was maintained at 36–38
°C by placing the rats on a thermal blanket. Animals
were submitted to a midline laparotomy, and ischemia
was induced by bilateral renal pedicle clamping for 60
min (with the exception of the sham group) with smooth
vascular clamps, as previously described (Mahfoudh
Boussaid et al., 2012). After the clamps were released,
the incisions were closed by running suture, and rats
were allowed to recover and kept warm. Five hours later,
animals were again submitted to anesthesia and catheters
were inserted into: i. the bladder for urine collection
during the last 30 min of reperfusion; ii. the right carotid
artery to control the mean arterial pressure (Pression
Monitor BP-1; Pression Instruments, Sarasota, FL, USA)
and collect blood samples; and iii. the left jugular vein
for mannitol (10%) and heparin (50 U/mL) infusion
(Minipuls 3 peristaltic pump, Gilson, France). At the end
of the reperfusion period (6 h), rats were euthanized and
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plasma, urine, and tissue samples were stored at –80 °C
until analyzed.
2.4. Renal function
As previously described by Mahfoudh Boussaid et al.
(2012), renal function was assessed in terms of creatinine
clearance calculated using the following formula:
Creatinine clearance (µL/min per g kidney weight) =
(creat u × V)/creat p, where
creat u = creatinine concentration in urine (µmol/L),
V = urine flow (µL/min/g kidney weight), and
creat p = creatinine concentration in plasma (µmol/L).
Creatinine concentrations in plasma and urine were
measured using a standard diagnostic kit (BioMérieux,
France).
2.5. Lactate dehydrogenase activity
Lactate dehydrogenase (LDH) activity in plasma was
measured to evaluate cytolysis using a commercial assay
kit, according to manufacturer’s instructions (Spinreact,
Spain).
2.6. Lipid peroxidation
Lipid peroxidation was determined by measuring the
formation of malondialdehyde (MDA) in renal tissue with
the thiobarbiturate reaction (Ben Mosbah et al., 2006).
2.7. Histological analysis
Renal biopsies were fixed in 10% formaldehyde solution
and then dehydrated and processed in paraffin according
to routine protocols. Renal specimens were then sectioned
(8 µm) and stained with standard hematoxylin-eosin
(H&E). A total of 10 sections per kidney were observed
by light microscopy at a magnification of 40–400 by an
experienced pathologist who had no information about
the treatment groups. The extent of renal necrosis was
semiquantitatively evaluated and scored from 0 to 4, as
reported by Jablonski et al. (1983). The scoring system is as
follows: 0: normal; 1: necrosis of individual cells; 2: necrosis
of all cells in adjacent proximal convoluted tubule (PCT),
with survival of surrounding tubules; 3: necrosis confined
to distal third PCT with bands of necrosis extending across
inner cortex; 4: necrosis of all three segments of PCT.
2.8. Superoxide dismutase activity
The total (Cu-Zn and Mn) superoxide dismutase (SOD)
activity in renal tissue was determined according to the
method of Marklund and Marklund (1974). It is based on
the inhibition of pyrogallol oxidation. One unit of SOD
was defined as the enzyme amount causing 50% inhibition
of pyrogallol oxidation. The SOD activity was measured at
420 nm and expressed as U/mg protein.
2.9. Catalase activity
The renal activity of catalase was measured using the
method described by Claiborne (1985). It consists of
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following the decomposition rate of hydrogen peroxide
spectrophotometrically at 240 nm. Results were expressed
as µmol H2O2 decomposed/mg protein per min.

2.10. Glutathione peroxidase activity
Glutathione peroxidase (GPx) activity in the kidney was
quantified by measuring the decrease in absorbance at
412 nm of glutathione (GSH) in the presence of H2O2 as
reported by Flohe and Gunzler (1984). The activity was
expressed as µmol oxidized GSH/min per mg protein.
2.11. Sulfhydryl content
The sulfhydryl content was estimated by measuring
protein-bound sulfhydryls (PSH) and GSH concentrations
in the renal tissue. PSH concentration was determined by
subtracting the nonprotein sulfhydryl (NPSH) content
from the total sulfhydryl content (TSH) (Sedlak and
Lindsay, 1968). TSH and NPSH contents were measured at
412 nm after the reaction with 5 5’-dithiobis 2-nitrobenzoic
acid (DTNB). Total GSH concentration in the kidney was
quantified at 412 nm by DTNB reaction, according to the
method described by Tietze (1969).
2.12. Western blotting
The kidney samples were homogenized as described
previously (Mahfoudh Boussaid et al., 2012). Tissue
lysates were then resolved by SDS-PAGE electrophoresis,
and proteins were transferred onto polyvinylidene fluoride
membranes. Blots were probed with antibodies against the
following proteins: total and p-AMPK, total and p-Akt,
total and phosphorylated glycogen synthase kinase-3 beta
(p-GSK3β), heat shock protein 70 (HSP70), p-P70S6K
(Cell Signaling Technology Inc., Beverly, MA, USA), total
and phosphorylated RNA-activated protein kinase (PKR)like ER kinase (p-PERK), activating transcription factor 4
(ATF4), CCAAT/enhancer binding protein homologous
protein (CHOP), tumor necrosis factor receptor-associated
factor 2 (TRAF2) (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), heme oxygenase 1 (HO-1), and b-actin
(Sigma, St Louis, MO, USA) and subsequently probed
with horseradish-peroxidase–conjugated polyclonal
antibodies. The bands were visualized using an enhanced
chemiluminescence kit (Bio Rad Laboratories, Hercules,
CA, USA). The values were obtained by densitometric
scanning and the Quantity One software program (Bio
Rad Laboratories).
2.13. Statistical analysis
Data are expressed as mean ± SEM values. Differences
between groups were examined for statistical significance
using one-way ANOVA followed by Newman–Keuls
multiple comparisons (Graph Pad Prism software, version
4 for Windows). The level of statistical significance was set
at P < 0.05.

3. Results
Immunoblot analysis of Figure 1 indicates that p-AMPK
levels were similar in both sham and I/R groups. AMPK
phosphorylation was significantly enhanced by melatonin
treatment compared to I/R group (P < 0.05). As expected,
the use of araA, an AMPK inhibitor, dramatically decreased
the levels of p-AMPK in comparison to all other groups (P
< 0.05).
As illustrated in the Table, animals that underwent
renal I/R exhibited a significant increase in LDH and
MDA levels, while their creatinine clearance and PSH
content decreased significantly in comparison to values
obtained from sham-operated rats (P < 0.05). Melatonin
treatment induced a significant reduction in LDH and
MDA and markedly raised the creatinine clearance and
PSH concentration as compared to the I/R group (P <
0.05). The inhibition of AMPK suppressed the effects of
melatonin in all of these parameters.
Histological evaluation of renal injury is consistent
with these biochemical parameters. In fact, kidneys of the
sham group did not show any histopathological changes
(Figure 2A), whereas features of renal damage and necrosis
including a consistent loss of nuclei, cell swelling, tubular
dilatation, and hemorrhage were markedly observed in
those belonging to the I/R group (Figure 2B). Although
a lower degree of injury was observed after melatonin
treatment (Figure 2C), the association of melatonin
with araA negated this improvement, and renal tissues
demonstrated severe tubular damage (Figure 2D).
These results were represented graphically in terms of
necrosis grading scale among the different groups (Figure
2E).
total AMPK
p -AMPK
*#

*# §

Figure 1. Western blot showing protein levels of phosphorylated
and total AMP-activated protein kinase in renal tissues after in
vivo ischemia/reperfusion. Representative blot is shown at the
top, and densitometric analysis is shown at the bottom. Results
are expressed as mean ± SEM (n = 6 for each group). * P < 0.05
vs. sham; # P < 0.05 vs. I/R; § P < 0.05 vs. Mel+I/R.
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Table. Evaluation of creatinine clearance, lactate dehydrogenase activity, protein-bound sulfhydryls, and malondialdehyde concentrations
among the different experimental groups.
Sham

I/R

Mel+I/R

Mel+I/R+araA

Creatinine clearance (μL/min/g)

613 ± 47

10 ± 3*

115 ± 3*#

11 ± 2*§

LDH (U/L)

700 ± 81

3838 ± 386*

1512 ± 412#

8486 ± 918*#§

PSH (µg/mg protein)

15 ± 1.5

6 ± 0.8*

17 ± 1.5#

9 ± 0.6*§

MDA (nmol/mg protein)

0.122 ± 0.02

0.6 ± 0.07*

0.28 ± 0.04#

0.5 ± 0.02*§

Results are expressed as mean ± SEM (n = 6 for each group). * P < 0.05 vs. sham; # P < 0.05 vs. I/R; § P < 0.05 vs. Mel+I/R.
A

B
H

D

E

H

L

* §

*

L
H D

D

*#

C

D

Figure 2. Representative histological photographs of kidney tissues from sham (A); I/R (B); Mel+I/R (C);
and Mel+I/R+araA (D) groups, (H&E) × 200. Semiquantitative assessment of renal necrosis among the
different experimental groups using the Jablonski score (E). H: hemorrhage, L: nuclei loss, and D: tubular
dilatation. Results are expressed as mean ± SEM (n = 6 for each group). * P < 0.05 vs. sham. # P < 0.05 vs.
I/R; § P < 0.05 vs. Mel+I/R.
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We then examined the possible involvement of
melatonin in stimulating other antioxidant systems and
whether this stimulation could be mediated by changes
in AMPK phosphorylation. I/R resulted in a significant
reduction in HO-1 level (Figure 3A) and GSH concentration
(Figure 3B) along with diminution of SOD (Figure 3C),
catalase (Figure 3D), and GPx (Figure 3E) activities in
the kidney in comparison to sham-operated animals (P
< 0.05). Rats treated with melatonin had significantly
higher antioxidant enzyme activities and HO-1 and GSH
content in their kidneys than nontreated animals (P <
0.05). In contrast, the administration of AMPK inhibitor
completely abolished the melatonin-mediated antioxidant
action; thus, catalase, SOD, and GPx activities and HO-1
and GSH amounts returned to I/R levels.
As a next step, we investigated the relationship between
melatonin, Akt, and AMPK pathways. Western blot
analyses show that p-Akt (Figure 4A), HSP70 (Figure 4B),
and p-P70S6K (Figure 4C) levels were markedly reduced

after I/R when compared to the sham group (P < 0.05).
However, there were no significant changes between the
I/R and sham groups regarding GSK-3β phosphorylation
(Figure 4D). Intraperitoneal injection of melatonin
produced a significant rise in p-Akt, HSP70, p-P70S6K,
and p-GSK-3β amounts in comparison to their relative I/R
groups. After araA administration, no significant changes
were observed in any of these parameters.
Finally, we focused on the role of AMPK in the
melatonin-mediated effect on endoplasmic reticulum (ER)
stress parameters. When compared to the sham-operated
group, renal I/R greatly enhanced p-PERK (Figure 5A),
ATF4 (Figure 5B), CHOP (Figure 5C), and TRAF2 levels
(Figure 5D) (P < 0.05). This activation was then significantly
attenuated by melatonin administration compared to the
I/R groups (P < 0.05). Combined pretreatment of the rats
with araA and melatonin significantly inhibited the effects
of melatonin alone; thus, p-PERK, ATF4, CHOP, and
TRAF2 levels rose noticeably (P < 0.05).

A.

B.
β actine
HO -1
#
*#
*

*§

C.

* §

*

E.

D.

#

#
#
*§
*
*

*§
*

*§

Figure 3. Western blot showing protein levels of heme oxygenase 1 and ß-actin. Representative blot is shown at the top, and densitometric
analysis is shown at the bottom (A). Glutathione concentration (B), superoxide dismutase activity (C), catalase activity (D), and
glutathione peroxidase activity (E) in renal tissues after in vivo ischemia/reperfusion. Results are expressed as mean ± SEM (n = 6 for
each group). * P < 0.05 vs. sham; # P < 0.05 vs. I/R; § P < 0.05 vs. Mel+I/R.
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A.

B.
total GSK 3ß
p - GSK - 3ß

total Akt
p -Akt

*#

* #

*

p-GSK-3 β (arbitrary
unit)

500

* #

400
300
200
100
0

C.

* #

Sham

I/R

Mel+I/R Mel+I/R+araA

D.

β actine
HSP 70

β actine
p -P70S6K
#

#

#

*

#

*

Figure 4. Western blot showing protein levels of phosphorylated and total Akt (A), heat shock protein 70 and ß-actin (B), phosphorylated
P70S6k and ß-actin (C), and phosphorylated and total glycogen synthase kinase-3β (D) in renal tissues after in vivo ischemia/reperfusion.
Representative blot is shown at the top, and densitometric analysis is shown at the bottom. Results are expressed as mean ± SEM (n = 6
for each group). * P < 0.05 vs. sham; # P < 0.05 vs. I/R; § P < 0.05 vss Mel+I/R.

4. Discussion
In this study, we shed some light on the molecular
mechanisms whereby melatonin modulates renal I/R injury.
These mechanisms appear to be dependent on AMPK
activation. The examination of AMPK phosphorylation
levels showed that melatonin treatment greatly enhanced
AMPK activation. Given the key role of AMPK in
modulating several signaling pathways, we hypothesized
that melatonin exerts its I/R-related protection through
its ability to activate AMPK. As a result, we examined the
effects of melatonin on some intracellular axes with and
without the use of an AMPK inhibitor.
The current study showed that exogenous melatonin
improved the renal function and cell integrity of ischemic
kidneys. Indeed, this effect was completely abolished by
the use of araA. In another context, it is well known that
oxidative damage to proteins and lipids is reflected by a
decrease in PSH level (Dubey et al., 1996) and an increase
in the level of MDA (Aktoz et al., 2007). Herein, melatonin
preconditioning was found to preserve the PSH pool and
decrease MDA formation. Again, this effect was notably
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suppressed subsequent to AMPK inhibition, suggesting
its involvement in the melatonin-related protective
mechanism regarding protein and lipid oxidation, renal
function, and cellular deterioration.
Oxidative damage to proteins and lipids might result
from alterations in antioxidant defense capacities. Our study
provides evidence that renal I/R causes a significant increase
in oxidative status, measured as a lower protein level of HO-1
as well as lower catalase, SOD, and GPx activities and GSH
content. As expected, pre-ischemic melatonin treatment
effectively enhanced these antioxidant systems. The blockage
of AMPK activation using araA completely suppressed
the antioxidant action of melatonin. This implies that the
induction of antioxidants produced by melatonin involves
activation of the AMPK signaling system. Interestingly, it
has been proven that p-AMPK induces expression of genes
involved in antioxidant defense, such as SOD, catalase, and
HO-1 (Wang et al., 2012b). This allows it to control the redox
balance and mitochondrial function and suppress the cell
death induced by oxidative stress, in addition to its traditional
role as an energy sensor (Kim et al., 2009).
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A.

B.
β actine
ATF4

total PERK
P-PERK
* §

*

*

* §

* #

#

C.

D.

β actine
CHOP

β actine
TRAF2
*

*

* #§

* §
#
* #

Figure 4

Figure 5. Western blot showing protein levels of phosphorylated and total RNA activated protein kinase (PKR)-like ER kinase (A),
activating transcription factor 4 and β-actin (B), CCAAT/enhancer binding protein homologous protein and β-actin (C), and tumor
necrosis factor receptor-associated factor 2 and β-actin (D) in renal tissues after in vivo ischemia/reperfusion. Representative blot is
shown at the top, and densitometric analysis is shown at the bottom. Results are expressed as mean ± SEM (n = 6 for each group). * P <
0.05 vs. sham; # P < 0.05 vs. I/R; § P < 0.05 vs. Mel+I/R.

With the aim of investigating other pathways that
melatonin could activate and discovering whether this
activation requires AMPK, the phosphorylation levels
of Akt and its downstream targets HSP70, P70S6K, and
GSK-3β were examined. Of marked interest was the
observation that melatonin treatment provoked significant
enhancement in p-Akt, HSP70, p-P70S6K, and p-GSK-3β
levels after renal I/R. This is important since Akt has been
shown to promote cell survival signals, in part, through
GSK-3β and P70S6K phosphorylation (Mahfoudh
Boussaid et al., 2012; Park et al., 2014) as well as HSP70
enhancement (Yeh et al., 2010). Notably, AMPK inhibition
had no significant effect on the melatonin-induced
activation of Akt, as our data showed. The examination
of HSP70, p-P70S6K, and p-GSK-3β levels further
supported the hypothesis that AMPK was not involved in
the melatonin-mediated activation of Akt. In light of these
findings, we suggest that there is no interaction between
the AMPK and Akt/HSP70/P70S6K/GSK-3β signaling
cascades.

The last step of this investigation consists of evaluating
the role of AMPK in the melatonin-mediated effect
on ER stress. We observed that the blockage of AMPK
activation restrained the melatonin-induced decrease in
p-PERK, ATF4, CHOP, and TRAF2. This confirms a close
relationship between AMPK and ER stress modulation.
Consistent with the present study, Zaouali et al. (2013)
reported the relevance of AMPK inhibition on an ERstress rise in hepatic I/R.
In conclusion, the present study elucidated some of
the molecular mechanisms whereby melatonin mediates
renoprotection during I/R. The signaling cascades involved
in this protection appear to be dependent on AMPK. This
may be particularly true for antioxidant capacities and ER
stress modulation, while the effect of melatonin on the Akt
pathway seems to be independent of AMPK.
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